Sort
8,912 grants matching “sars cov 2”
The External Exposome and COVID-19 Severity
$1Hui Hu · University Of Florida · R21 · FY2021 · ES
Identifying and evaluating prevention strategies for COVID-19 in correctional facilities
$1Margaret Lind · Yale University · K99 · FY2024 · AI
Pneumonia-induced microglial activation causes blood-brain barrier breakdown, astrocyte activation, and tau pathology
$1Samantha Dawn Chaney · University Of South Alabama · F99 · FY2025 · NS
Socio-Cultural Effects of the COVID-19/Extreme Heat Syndemic
$0Courtney E Cecale · University Of North Texas · · FY2022 · SBE
Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients with Interstitial Lung Disease
$0Leighton Chan · Clinical Center · ZIA · FY2023 · CL
Big Data - Epidemiology of Critical Illness and Sepsis
$0Sameer Kadri · Clinical Center · ZIA · FY2025 · CL
Big Data - Epidemiology of Critical Illness and Sepsis
$0Sameer Kadri · Clinical Center · ZIA · FY2024 · CL
Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons
$0Anthony F. Suffredini · Clinical Center · ZIA · FY2021 · CL
The Role of the Scavenger Receptor B Family Proteins (SR-BI, SR-BII and CD36) in Infection and Sepsis
$0Thomas Eggerman · Clinical Center · ZIA · FY2023 · CL
Molecular imaging of viral infections
$0Dima A Hammoud · Clinical Center · ZIA · FY2025 · CL
Vascular Dysfunction and Inflammation
$0Robert L Danner · Clinical Center · ZIA · FY2022 · CL
Preclinical and Clinical Investigations of Severe Infection and Critical Illness
$0Robert L Danner · Clinical Center · ZIA · FY2022 · CL
Clinical and Molecular Features of Coronavirus Disease 2019
$0Daniel S Chertow · Clinical Center · ZIA · FY2025 · CL
Identification of Clinically Important Microbes by Genomic and Proteomic Methods
$0Adrian Marcelo Zelazny · Clinical Center · ZIA · FY2023 · CL
Obtaining Samples from Human Subjects to Facilitate Basic, Translational and Clinical Research
$0Michael Solomon · Clinical Center · ZIA · FY2025 · CL
Understanding the Epidemiology of Adenovirus and its Evolution in Patients with Viremia
$0Sanchita Das · Clinical Center · ZID · FY2022 · CL
** AWARDS ISSUED PRIOR TO JANUARY 20, 2025, WERE FUNDED UNDER PREVIOUS ADMINISTRATIONS AND MAY NOT REFLECT THE PRIORITIES AND POLICIES OF THE CURRENT ADMINISTRATION.** THE SECONDARY SPREAD OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-COV-2) FROM HUMANS TO OTHER ANIMALS HAS BEEN EXTENSIVELY DESCRIBED IN MULTIPLE ANIMAL SPECIES. IN PARTICULAR, NATURAL SARS-COV-2 INFECTION OF WHITE-TAILED DEER ACROSS THE USA HAS BEEN DOCUMENTED. IT IS WELL-ESTABLISHED THAT DISEASE-CAUSING MICROORGANISMS CAN PASS BETWEEN DEER AND LIVESTOCK SPECIES SUCH AS CATTLE. THEREFORE, CONTINUED CIRCULATION OF SARS-COV-2 IN DEER POSES A SIGNIFICANT RISK OF INFECTION IN CATTLE AND PIGS. IN THIS REGARD, USING ADVANCED MOLECULAR APPROACHES, THIS PROJECT WILL ADDRESS CRITICAL QUESTIONS, CAN THE SARS-COV-2 ADAPTATION IN DEER MAKE IT MORE EFFICIENT TO INFECT CATTLE AND PIGS? AND HAVE THE NEW SARS-COV-2 VARIANTS SPILLED OVER INTO CATTLE AND PIGS IN THE USA? THE OUTCOMES OF THIS PROJECT ARE OF SIGNIFICANT RELEVANCE TO US ANIMAL AGRICULTURE AS DEER, CATTLE, AND PIGS ARE OF SUBSTANTIAL ECONOMIC IMPORTANCE AND SHAPE THE LIVELIHOODS AND CULTURE OF REGIONS THROUGHOUT THE UNITED STATES.
$0The Pennsylvania State University · · FY2023 · National Institute of Food and Agriculture
Role of Class B Scavenger Receptors in Lipid Metabolism and Inflammation
$0Amy Pate Patterson · Clinical Center · ZIA · FY2025 · CL
COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE): A Randomized Controlled Trial
$0Leighton Chan · Clinical Center · ZIA · FY2023 · CL
Cellular and Molecular Consequences of SARS-CoV2 Infection in Pulmonary Vascular Endothelium
$0Jason Matthew Elinoff · Clinical Center · ZIA · FY2022 · CL
** AWARDS ISSUED PRIOR TO JANUARY 20, 2025, WERE FUNDED UNDER PREVIOUS ADMINISTRATIONS AND MAY NOT REFLECT THE PRIORITIES AND POLICIES OF THE CURRENT ADMINISTRATION.** SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS?COV?2) DEMONSTRATED THE ABILITY TO INFECT MANY ANIMAL SPECIES. WIDESPREAD NATURAL SARS-COV-2 INFECTION OF WHITE-TAILED DEER IN THE USA RAISED CONCERNS ABOUT THEIR ROLE AS A RESERVOIR OF SARS-COV-2. AS THE VIRUS CONTINUES TO CIRCULATE IN ANIMALS, IT IS LIKELY TO MUTATE AND COULD THREATEN THE HEALTH OF AGRICULTURAL ANIMALS. THEREFORE, IT IS CRITICAL TO MONITOR THE NATURAL SARS-COV-2 INFECTION OF ANIMALS AND THE GENETIC CHANGES IN THE VIRUS. CURRENT METHODS FOR DETECTING AND GENETIC SEQUENCING OF SARS-COV-2 REQUIRE EXPENSIVE INSTRUMENTATION, ARE NOT STANDARDIZED FOR ANIMAL SAMPLES, AND ARE UNSUITABLE FOR FIELD APPLICATION. HENCE, THIS PROJECT AIMS TO DEVELOP AND VALIDATE HIGHLY SENSITIVE, COST-EFFECTIVE, AND FLEXIBLE NANOPORE-BASED MOLECULAR METHODS TO MONITOR THE CIRCULATION OF SARS-COV-2 IN AGRICULTURAL ANIMALS. THE PROJECT WILL SUPPORT EFFECTIVE SURVEILLANCE OF SARS-COV-2 INFECTION OF ANIMALS THROUGH THE RAPID DETECTION AND CHARACTERIZATION OF SARS-COV-2.
$0The Pennsylvania State University · · FY2023 · National Institute of Food and Agriculture
The Role of the Scavenger Receptor B Family Proteins (SR-BI, SR-BII and CD36) in Infection and Sepsis
$0Thomas Eggerman · Clinical Center · ZIA · FY2022 · CL
COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE): A Randomized Controlled Trial
$0Leighton Chan · Clinical Center · ZIA · FY2024 · CL
The Effects of Oxygen Therapy on Mouse Hepatitis Coronavirus Induced Pneumonia
$0Parizad Torabi-Parizi · Clinical Center · ZIA · FY2022 · CL
Molecular imaging of viral infections
$0Dima A Hammoud · Clinical Center · ZIA · FY2024 · CL